Acadian Asset Management LLC Boosts Stock Holdings in Phreesia, Inc. $PHR

Acadian Asset Management LLC boosted its stake in shares of Phreesia, Inc. (NYSE:PHR) by 61.6% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 364,194 shares of the company’s stock after purchasing an additional 138,877 shares during the quarter. Acadian Asset Management LLC owned approximately 0.61% of Phreesia worth $10,357,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the company. Diversified Trust Co lifted its position in shares of Phreesia by 1.0% during the 2nd quarter. Diversified Trust Co now owns 45,042 shares of the company’s stock worth $1,282,000 after purchasing an additional 426 shares during the last quarter. Oppenheimer Asset Management Inc. increased its holdings in Phreesia by 9.9% in the second quarter. Oppenheimer Asset Management Inc. now owns 8,803 shares of the company’s stock valued at $251,000 after buying an additional 792 shares during the last quarter. Bank of Montreal Can raised its stake in Phreesia by 9.2% in the second quarter. Bank of Montreal Can now owns 11,277 shares of the company’s stock valued at $321,000 after buying an additional 950 shares in the last quarter. Probity Advisors Inc. lifted its holdings in Phreesia by 9.7% during the 2nd quarter. Probity Advisors Inc. now owns 13,211 shares of the company’s stock worth $376,000 after buying an additional 1,168 shares during the last quarter. Finally, Hsbc Holdings PLC lifted its holdings in Phreesia by 9.0% during the 1st quarter. Hsbc Holdings PLC now owns 14,241 shares of the company’s stock worth $356,000 after buying an additional 1,177 shares during the last quarter. 92.10% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Phreesia news, General Counsel Allison C. Hoffman sold 3,133 shares of the company’s stock in a transaction that occurred on Tuesday, September 16th. The stock was sold at an average price of $23.28, for a total transaction of $72,936.24. Following the completion of the sale, the general counsel directly owned 139,037 shares of the company’s stock, valued at $3,236,781.36. This represents a 2.20% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Evan Roberts sold 45,147 shares of the stock in a transaction that occurred on Wednesday, August 27th. The stock was sold at an average price of $32.02, for a total value of $1,445,606.94. Following the sale, the insider directly owned 727,768 shares of the company’s stock, valued at $23,303,131.36. The trade was a 5.84% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 92,244 shares of company stock worth $2,680,720. Insiders own 5.50% of the company’s stock.

Phreesia Stock Performance

Shares of PHR opened at $22.75 on Wednesday. The company’s 50 day simple moving average is $23.81 and its 200-day simple moving average is $25.88. The firm has a market cap of $1.36 billion, a PE ratio of -54.17 and a beta of 0.74. Phreesia, Inc. has a 12-month low of $17.07 and a 12-month high of $32.76. The company has a current ratio of 2.12, a quick ratio of 2.12 and a debt-to-equity ratio of 0.02.

Phreesia (NYSE:PHR) last issued its quarterly earnings results on Thursday, September 4th. The company reported $0.01 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.08. The firm had revenue of $117.26 million during the quarter, compared to analysts’ expectations of $116.39 million. Phreesia had a negative net margin of 5.35% and a negative return on equity of 8.75%. Phreesia’s quarterly revenue was up 14.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.03) EPS. Phreesia has set its FY 2026 guidance at EPS. As a group, equities analysts predict that Phreesia, Inc. will post -1.1 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the company. Stephens reissued an “overweight” rating and set a $32.00 target price on shares of Phreesia in a research report on Wednesday, September 3rd. Citigroup reiterated an “outperform” rating on shares of Phreesia in a research note on Monday, September 8th. Raymond James Financial set a $33.00 price objective on shares of Phreesia and gave the stock an “outperform” rating in a research report on Friday, September 5th. Truist Financial upped their target price on shares of Phreesia from $35.00 to $36.00 and gave the company a “buy” rating in a report on Friday, September 5th. Finally, Needham & Company LLC lifted their price target on shares of Phreesia from $29.00 to $35.00 and gave the stock a “buy” rating in a research note on Friday, September 5th. One investment analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and one has issued a Sell rating to the company. According to MarketBeat, Phreesia presently has an average rating of “Moderate Buy” and a consensus price target of $33.85.

Phreesia Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.